Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection

Patients with COVID-19 may suffer from hemorrhagic complications. Our article highlights two cases of COVID-19-infected patients, who suffered severe epistaxis after initiation of intravenous recombinant tissue plasminogen activator (IV-rtPA) for acute ischemic stroke, followed by a sudden decline i...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandelwal, Priyank, Martínez-Pías, Enrique, Bach, Ivo, Prakash, Tannavi, Hillen, Machteld E., Martínez-Galdámez, Mario, Arenillas, Juan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191532/
https://www.ncbi.nlm.nih.gov/pubmed/34189359
http://dx.doi.org/10.4103/bc.bc_17_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191532/
https://www.ncbi.nlm.nih.gov/pubmed/34189359
http://dx.doi.org/10.4103/bc.bc_17_21

Ejemplares similares